Atropine Sulfate

硫酸阿托品

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameAtropine Sulfate
Drug Alias Name硫酸阿托平Atropine sulphate阿托品硫酸盐Hyoscyamine SulfateMicroPine +[25] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsCycloplegiaOrganophosphate PoisoningPoisoning +[22] 
Global Approved IndicationsPoisoningPainMyocardial Infarction +[7] 
Approved Indications in ChinaPoisoningPainArrhythmias, Cardiac
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesVietnam +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityIDB VisionCare SDN BHDOcus Innovation Ireland Ltd +[18] 
Inactive CompaniesAmani Hassan Abdel-WahabTianjin Jinyao Group Hebei Yongguang Pharmaceutical Co LtdNanjing Ruinian Best Pharmaceutical Co Ltd +[21] 
Active IndicationsCycloplegiaPoisoningPain +[17] 
Inactive IndicationsOrganophosphate PoisoningEye DiseasesRespiratory Distress Syndrome, Newborn +[5] 

Other Information

ATC CodeA03BA01S01FA01
Related LinksWikipediaDrugBankKEGG